<DOC>
	<DOCNO>NCT00193661</DOCNO>
	<brief_summary>This study observe efficacy safety T-Gel 1 % treatment delay puberty adolescent . Subjects complete trial may enter 3 month extension study ( UMD-01-090E ) .</brief_summary>
	<brief_title>Observation Study T-Gel ( 1 % ) Treatment Adolescent Boys With Hypogonadism</brief_title>
	<detailed_description />
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Primary secondary hypogonadism constitutional delay growth puberty ( CDGP ) Skin intolerance alcohol allergy soy Generalized skin disease Contraindication testosterone androgen product</criteria>
	<gender>Male</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>September 2006</verification_date>
	<keyword>Hypogonadism</keyword>
</DOC>